Sleep Diagnostic Test: ApneaLink™ Plus

Sleep apnea – a ‘hidden epidemic’ for too long

Sleep apnea has been silently troubling millions of people worldwide. Obstructive sleep apnea (OSA) is one of the most common forms of sleep-disordered breathing (SDB). SDB affects not only patients’ sleep, but their waking lives, health and safety. The risks are multiplied for patients with hypertension, cardiac problems and diabetes.

ApneaLink – identify those who are most at risk
  • Easy and accurate
  • Comfortable and convenient
  • Simple reporting with graphic risk indicators
  • Optional oximetry
Which patients need to be screened?

A range of symptoms and comorbidities may accompany SDB.

  • Loud irregular snoring
  • Pronounced daytime fatigue and drowsiness
  • Impaired concentration and irritability
  • Hypertension
  • Stroke
  • Diabetes Mellitus Type II
  • Erectile dysfunction
Easy for patients to use in the comfort of their own home
  • Worn like a belt, around the chest area
  • Lightweight, does not disrupt sleep
  • Easy to use, attach and detach
Untreated SDB – the consequences
  • One out of 20 adults suffer from SDB1.
  • A significant percentage remain untreated.
  • 9.1% of work-related injuries are attributed to sleep disorders2 and people with untreated sleep apnea are at increased risk of a workplace accident.
  • SDB is associated with serious comorbidities such as hypertension, cardiac problems and diabetes.

1. Young T, Peppard P, et al. Epidemiology of OSA. Am J Respir Crit Care Med 2002, 165:1217-35
2. Wake up Australia: the value of healthy sleep. Report by Access Economics Pty Ltd for Sleep Health Australia: 2005